FI105025B - Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia - Google Patents

Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia Download PDF

Info

Publication number
FI105025B
FI105025B FI944546A FI944546A FI105025B FI 105025 B FI105025 B FI 105025B FI 944546 A FI944546 A FI 944546A FI 944546 A FI944546 A FI 944546A FI 105025 B FI105025 B FI 105025B
Authority
FI
Finland
Prior art keywords
phenyl
preparation
ethanamine
pyridine
compound
Prior art date
Application number
FI944546A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944546A (fi
FI944546A0 (fi
Inventor
Ronald Conrad Griffith
Robert John Murray
Michael Balestra
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207339A external-priority patent/GB9207339D0/en
Priority claimed from GB929208290A external-priority patent/GB9208290D0/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI944546A publication Critical patent/FI944546A/fi
Publication of FI944546A0 publication Critical patent/FI944546A0/fi
Application granted granted Critical
Publication of FI105025B publication Critical patent/FI105025B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI944546A 1992-04-03 1994-09-30 Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia FI105025B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
GB9207339 1992-04-03
GB929208290A GB9208290D0 (en) 1992-04-15 1992-04-15 Pharmaceutical compound having neuroprotective properties
GB9208290 1992-04-15
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
GB9300689 1993-04-01

Publications (3)

Publication Number Publication Date
FI944546A FI944546A (fi) 1994-09-30
FI944546A0 FI944546A0 (fi) 1994-09-30
FI105025B true FI105025B (fi) 2000-05-31

Family

ID=26300643

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944546A FI105025B (fi) 1992-04-03 1994-09-30 Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia

Country Status (29)

Country Link
EP (1) EP0633879B1 (ja)
JP (2) JP3120810B2 (ja)
KR (1) KR100259567B1 (ja)
CN (1) CN1044367C (ja)
AT (1) ATE163925T1 (ja)
AU (2) AU3897693A (ja)
CA (1) CA2133427C (ja)
CZ (1) CZ288519B6 (ja)
DE (1) DE69317411T2 (ja)
DK (1) DK0633879T3 (ja)
DZ (1) DZ1677A1 (ja)
ES (1) ES2115055T3 (ja)
FI (1) FI105025B (ja)
HK (1) HK1009331A1 (ja)
HU (1) HU211529A9 (ja)
IL (1) IL105276A (ja)
MA (1) MA22866A1 (ja)
MX (1) MX9301935A (ja)
MY (1) MY110149A (ja)
NO (1) NO302170B1 (ja)
NZ (1) NZ251384A (ja)
PL (1) PL180014B1 (ja)
RU (1) RU2128650C1 (ja)
SG (1) SG47948A1 (ja)
SK (1) SK281258B6 (ja)
TW (1) TW282455B (ja)
UA (1) UA29437C2 (ja)
WO (1) WO1993020052A1 (ja)
ZA (1) ZA932415B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ES2083972T3 (es) * 1988-08-12 1996-05-01 Astra Ab Arilalquil-aminas y -amidas con propiedades anticonvulsivas y neuroprotectoras.
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
WO2007017652A2 (en) * 2005-08-10 2007-02-15 Astrazeneca Ab Arylakylamines for the treatment of cancer
MX2011006680A (es) * 2008-12-24 2011-07-12 Astrazeneca Ab Compuestos etanaminicos y su uso para tratar la depresion.
JP2015501652A (ja) 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ Ｇａｂｒ−ａ２診断
SI3066091T1 (sl) 2013-11-05 2019-09-30 Astrazeneca Ab NMDA antagonist predzdravila
WO2021262779A1 (en) * 2020-06-23 2021-12-30 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083972T3 (es) * 1988-08-12 1996-05-01 Astra Ab Arilalquil-aminas y -amidas con propiedades anticonvulsivas y neuroprotectoras.

Also Published As

Publication number Publication date
UA29437C2 (uk) 2000-11-15
EP0633879B1 (en) 1998-03-11
AU7545696A (en) 1997-02-13
HU211529A9 (en) 1995-11-28
FI944546A (fi) 1994-09-30
DZ1677A1 (fr) 2002-02-17
FI944546A0 (fi) 1994-09-30
NO943645D0 (no) 1994-09-30
WO1993020052A1 (en) 1993-10-14
CN1044367C (zh) 1999-07-28
MA22866A1 (fr) 1993-12-31
CN1081669A (zh) 1994-02-09
SK117794A3 (en) 1995-05-10
ZA932415B (en) 1993-10-22
SG47948A1 (en) 1998-04-17
JPH07505385A (ja) 1995-06-15
IL105276A (en) 1997-06-10
DK0633879T3 (da) 1998-09-28
RU2128650C1 (ru) 1999-04-10
MY110149A (en) 1998-02-28
TW282455B (ja) 1996-08-01
CZ288519B6 (cs) 2001-07-11
DE69317411T2 (de) 1998-07-30
DE69317411D1 (de) 1998-04-16
ES2115055T3 (es) 1998-06-16
HK1009331A1 (en) 1999-05-28
PL180014B1 (pl) 2000-11-30
ATE163925T1 (de) 1998-03-15
NO943645L (no) 1994-11-16
CZ240994A3 (en) 1995-12-13
KR100259567B1 (ko) 2000-07-01
JP3120810B2 (ja) 2000-12-25
CA2133427C (en) 2003-06-10
AU705419B2 (en) 1999-05-20
SK281258B6 (sk) 2001-01-18
IL105276A0 (en) 1993-08-18
NZ251384A (en) 1996-10-28
JP2000319259A (ja) 2000-11-21
AU3897693A (en) 1993-11-08
NO302170B1 (no) 1998-02-02
EP0633879A1 (en) 1995-01-18
RU94042465A (ru) 1996-07-20
CA2133427A1 (en) 1993-10-14
MX9301935A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
DE60131032T2 (de) Verwendung von antikonvulsiven Aminosäure zur Behandlung von Migräne
DE60107435T2 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
FI105025B (fi) Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia
CA2159478C (en) (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament
DE69924979T2 (de) Behandlung von chronischen schmerzen
CN110719779B (zh) 包含非外消旋比例的(r)-地来西坦(1)和(s)-地来西坦(2)的协同组合物
US5455259A (en) Compounds for the treatment of neurodegenerative disorders
AU639722B2 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
CA2159480C (en) (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament
RU2637928C2 (ru) Производные арилциклоалкиламинов, нейропротектор (варианты), вещество, обладающее сочетанным нейропротекторным, анальгетическим и антидепрессивным действием, фармацевтические композиции на его основе
TW390875B (en) (S) -<alpha>-phenyl-2-pyridineethanamine (S)-malate useful in therary, its perparing process and pharmaceutical composition comprising the same
EA041317B1 (ru) Синергетические композиции, содержащие (r)-димирацетам (1) и (s)-димирацетам (2) в нерацемическом соотношении

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ASTRA AB

MA Patent expired